MRI Interventions Enters At-The-Market Equity Offering Sales Agreement
On November 7, 2024, MRI Interventions (OTCMKTS: MRIC) announced that it has entered into an At-The-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated. The Company aims to sell shares of its common stock, par value $0.01 per share, with an aggregate sales value of up to $50 million through this agreement. According […]
More Stories
Zotefoams (LON:ZTF) Hits New 1-Year Low – Here’s Why
Zotefoams plc (LON:ZTF – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock...
Mineralys Therapeutics (NASDAQ:MLYS) Shares Down 9.6% – Here’s Why
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report)’s stock price traded down 9.6% on Wednesday . The company traded as...
Britvic (LON:BVIC) Hits New 12-Month High – Should You Buy?
Britvic plc (LON:BVIC – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday ....
RBG (LON:RBGP) Sets New 12-Month Low – Time to Sell?
Shares of RBG Holdings plc (LON:RBGP – Get Free Report) hit a new 52-week low during trading on Wednesday ....
Lattice Semiconductor Adopts 2025 Inducement Equity Incentive Plan
Lattice Semiconductor Corporation, a Delaware-based company specializing in semiconductor technology, announced on January 9, 2025, the adoption of the Lattice...
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 3.9% – Here’s What Happened
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report)’s stock price shot up 3.9% during trading on Wednesday . The stock...